Jamieson is pleased to announce that it has advised the management team of Kynetec, a leader in agricultural and animal health market research, data and insights, on the sale of the business to US-based Paine Schwartz Partners from Inflexion. The transaction follows a nearly five-year partnership with Inflexion which delivered strong UK and international returns.
“Following a successful last five years with Inflexion, we are very excited to continue our journey with Paine Schwartz Partners. The investment by Paine Schwartz will provide us resources to capture opportunities, while bringing us a partner with deep agribusiness experience and expertise. We look forward to working closely with the Paine Schwartz team to continue building out our offerings, capabilities and customer base while extending our leadership in agriculture and animal health market research. A special thanks to John, Tom, and Alison at Jamieson for their tremendous support and tireless efforts through the process.”
Daniel Wirth, CEO
Kynetec provides market research for the agriculture and animal health industries, helping companies around the world understand the dynamics of their marketplaces, turning research into business opportunities and enabling clients to create winning strategies. Led by an experienced management team and based in Newbury, England and St. Louis, Missouri, Kynetec has 400-plus customers in more than 80 countries.
The business has a global footprint with employee shareholders in ~20 countries. The senior executive team is based in the UK and US – a growing trend in mid-market PE backed businesses. With offices in the US and UK, Jamieson was well placed to support the executive team through the transaction, understanding and assisting with some of the challenges on the way to a successful execution.
John Greenland, Tom Darley and Alison Dunning advised CEO Daniel Wirth and the management team as part of the transaction and on the terms of the new management incentive arrangements.
